Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 4, 2021 at 11:12 AM.

  1. #1 cafead, Feb 4, 2021 at 11:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Pfizer has teamed up with Imcyse to develop treatments for rheumatoid arthritis. The agreement will give Pfizer the chance to access modified peptides designed to induce cytolytic T cells and thereby eliminate the disease pathway without affecting the rest of the immune system.

    article source
     
    Quote

Reply to Thread